Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Testicular, Ovarian, Bladder, Lung, Colorectal, Gastric, and Head & Neck Cancers.
Multiple Myeloma and Myelodysplastic Syndromes.
Brain Tumors (Glioblastoma, Astrocytoma), Multiple Myeloma, Lymphomas, Leukemias, Sarcomas, and conditioning regimens.
Brain Tumors (Glioblastoma, Astrocytoma), Multiple Myeloma, Lymphomas, Leukemias, Sarcomas, and conditioning regimens.
Relapsed or refractory B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Mantle Cell Lymphoma, or Multiple Myeloma.
Non-metastatic and metastatic Castration-Resistant and Castration-Sensitive Prostate Cancer.
Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.
ALK-positive and ROS1-positive metastatic Non-Small Cell Lung Cancer.
Prevention of HPV-associated cervical, vulvar, vaginal, anal, and oropharyngeal cancers.
KRAS wild-type Metastatic Colorectal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Non-Small Cell Lung Cancer.